|
|
Other links at Articles > Business of Medicine |
| 2. |
FDA Reprimands GlaxoSmithKline Over Missing Data on Rosiglitazone
|
|
|
In a letter to GlaxoSmithKline, the FDA said that an inspection in late 2007 focusing on compliance with postmarketing adverse drug experience reporting requirements found that the company failed to report data from clinical usage and failed to disclose or submit data from clinical trials. Heartwire
|
| 5. |
Merit Medical Gets FDA Nod for Two Devices
|
|
|
Merit Medical Systems Inc, which makes disposable medical devices, said it received regulatory clearance to sell its All Star hemostasis valve and the Prelude marker tip introducer sheath. Reuters Health Information
|
|
|